2.Analysis of the hepatitis B report data on pilot surveillance in 200 counties in China, 2013.
Ning MIAO ; Guomin ZHANG ; Hui ZHENG ; Zhenhua WU ; Xiaojin SUN ; Feng WANG ; Fuzhen WANG ; Fuqiang CUI ; Li LI
Chinese Journal of Preventive Medicine 2015;49(9):766-770
OBJECTIVETo analyze the information of the supplementary card for hepatitis B and the laboratory confirmed result of immunoglobulin M antibody to hepatitis B virus (HBV) Core Antigen (anti-HBc IgM) for the suspected acute hepatitis B to evaluate the hepatitis B report data on pilot surveillance.
METHODS200 counties were established in China for hepatitis B pilot surveillance and 63 641 cases were reported. We added a supplementary card in National Notificable Disease Reporting System (NNDRS) and all the reported hepatitis B cases in NNDRS were required to fill the supplementary card. Venous blood 5 ml was collected and a confirmed test of anti-HBc IgM was made for suspected acute hepatitis B. We made confirmed diagnosis for the suspected acute hepatitis B according to the supplementary card information of the reporting card and the confirmed test result of anti-HBc IgM.
RESULTS63 641 hepatitis B cases were reported in 200 hepatitis B pilot surveillance counties in 2013. Among 1 723 cases which were filled with the HBsAg positive within six months in supplementary card, 735 cases were reported as chronic hepatitis B, the proportion was 42.66%. Among 4 582 cases which were filled with anti-HBc IgM positive in supplementary card, 2 436 cases were reported as acute hepatitis B, the proportion was 53.16%. 1 829 cases were reported as chronic hepatitis B, the proportion was 39.92%. The validity cases of the information for liver puncture and the HBV surface antigen (HBsAg) transform during the recovery period in supplementary cards for all the reporting cases were 579 and 4 961, and the rate were 0.91% and 7.80%, respectively. 4 302 suspected acute cases were made confirmed diagnosis, and 1 197 cases (27.82%) were confirmed acute and 2 590 cases (60.20%) were confirmed chronic.
CONCLUSIONClinical doctors failed to make full use of the information of supplementary cards to make classification diagnose for hepatitis B. Suspected acute hepatitis B with anti-HBc IgM positive should be pay attention to follow up and further distinguish acute or chronic hepatitis B according to the HBsAg transform.
China ; epidemiology ; Hepatitis B ; epidemiology ; Hepatitis B Antibodies ; blood ; Hepatitis B Core Antigens ; immunology ; Hepatitis B Surface Antigens ; immunology ; Humans ; Immunoglobulin M ; blood ; Sentinel Surveillance
3.Epidemiology and prevention of hepatitis B virus infection.
So Young KWON ; Chang Hong LEE
The Korean Journal of Hepatology 2011;17(2):87-95
Hepatitis B virus (HBV) infection has been a major global cause of morbidity and mortality. The recognition of the problem led to a worldwide effort to reduce transmission of HBV through routine infant vaccination. HBV infection is the most common cause of chronic liver diseases and hepatocellular carcinoma in Korea. After hepatitis B vaccine era, seroprevalence of hepatits B surface antigen is decreasing, particularly in children. Hepatitis B vaccine is remarkably safe and shows high immunogenicity. Universal childhood immunization with three doses of hepatitis B vaccine in the first year of life is a highly effective method for prevention and control of hepatitis B.
Hepatitis B/*epidemiology/immunology/*prevention & control
;
Hepatitis B Antibodies/blood/immunology
;
Hepatitis B Vaccines/immunology/therapeutic use
;
Hepatitis B virus/genetics/immunology
;
Humans
;
Vaccination
4.Epidemiology of hepatitis E in clinical patients in Dongtai, Jiangsu province.
Xin YAO ; Cheng ZHOU ; Feng-cai ZHU ; Xing WU ; Xue-feng ZHANG ; Zhong-ze WANG ; Chuan JI ; Zheng-lun LIANG
Chinese Journal of Epidemiology 2010;31(5):594-594
China
;
epidemiology
;
Female
;
Hepatitis E
;
blood
;
epidemiology
;
Hepatitis E virus
;
immunology
;
Humans
;
Immunoglobulin M
;
blood
;
Male
;
Middle Aged
5.Investigation of sub-clinical infection of hepatitis E virus in blood donors.
Dong-ying GAO ; Geng PENG ; Jia-ming ZHU ; Li SUN ; Ying-jie ZHENG ; Jun ZHANG
Chinese Journal of Hepatology 2004;12(1):11-12
OBJECTIVETo understand the prevalence of sub-clinical infection of hepatitis E virus (HEV) among blood donors.
METHODSA cluster sampling strategy was used to sample all blood donors from July to August in 2002 in Beijing. Their blood was tested for IgM and IgG antibody against HEV.
RESULTSThe prevalence of anti-HEV IgM among blood donors in Beijing was 1.74%. The rate of abnormal alanine aminotransferase (ALT) in anti-HEV IgM positive donors is significantly higher than anti-HEV IgM negative donors. Among all ALT abnormal donors, 2.68% can be associated with HEV sub-clinical infection. The percentage is similar with HBV but higher than HCV.
CONCLUSIONThere are sub-clinical infection of HEV among blood donors, which is one of the cause of abnormal ALT in the donors.
Adult ; Alanine Transaminase ; blood ; Blood Donors ; Female ; Hepacivirus ; immunology ; Hepatitis Antibodies ; blood ; Hepatitis E ; epidemiology ; Hepatitis E virus ; immunology ; Humans ; Immunoglobulin M ; blood ; Male
6.Preliminary study on genotype of hepatitis B virus detected from Tibetans in China.
Yan-qing XU ; Yong-dong ZHOU ; Sheng-li BI
Chinese Journal of Experimental and Clinical Virology 2005;19(2):118-120
OBJECTIVETo determine the main genotype of hepatitis B virus (HBV) detected from Tibetans in China and provide basic data for hepatitis control and prevention.
METHODSThe S gene and C gene were amplified by PCR from the sera of HBsAg positive Tibetans. After sequencing, the gene sequences were analyzed and the phylogenetic trees were drawn by the software MEGA3.
RESULTSIn trees based on S gene, the sequences of most samples clustered at genotype D, while in trees based on C gene, the sequences of all samples clustered at genotype C.
CONCLUSIONThe dominant genotype of HBV detected from Tibetans in China is a C/D hybrid.
Genotype ; Hepatitis B ; blood ; epidemiology ; virology ; Hepatitis B Core Antigens ; genetics ; Hepatitis B Surface Antigens ; blood ; genetics ; Hepatitis B virus ; classification ; genetics ; immunology ; Humans ; Phylogeny ; Tibet ; epidemiology
7.Observation on effects of hepatitis B vaccine immunization for 12 years in children in Beijing.
Xiao-hong GONG ; Fu-zhen WANG ; Hui LI ; Li-rong LIU ; Yang-hua LI ; Bao-lan WANG ; Li-qin LI ; Zhen ZHANG ; Qing-ying HAN ; Yao-wu TANG
Chinese Journal of Preventive Medicine 2005;39(4):265-268
OBJECTIVETo evaluate the long-term protective effects of hepatitis B vaccine after immunizing to the children for 12 years in Beijing.
METHODSThe multiple stratified cluster sampling was used in this epidemiological survey. The sampling children's blood serum HBsAg, anti-HBs and anti-HBc were checked and measured by the solid phase radioimmunoassay (SPRIA). The serological level of these index and the causes of the children with HBsAg positive were analyzed.
RESULTSThere were 2,419 cases 3-12 years-old children immunized with the hepatitis B vaccine in infant period were surveyed and the total HBsAg positive rate was 0.52%. The vaccine protective rate was 88.45% (95% CI: 65.67%-97.89%). The total anti-HBc positive rate was 2.21%, being no statistical significance among the age groups. The average anti-HBs positive rate of 3-6 years-old children immunized with gene recombining vaccine was 38.79% and descending greatly following the age's dropping. The geometric means of anti-HBs serological titer (GMT) was 52.83 mIU/ml, showing no statistical significance among the age groups. The average anti-HBs positive rate of 6-12 years-old children immunized with the blood rooting vaccine was 50.79%. The geometric means of anti-HBs serological titer (GMT) was 61.51 mIU/ml. There were no statistical significances among the age groups. Among the HBsAg positive children, more than 50% of the children's mothers were HBsAg positive also.
CONCLUSIONSThe protective effects given by immunization were significant after the hepatitis B vaccine vaccination for 12 years in Beijing. The booster immunization was not necessary, because the HBsAg positive rate didn't ascend obviously as the immunization time prolonging. As the anti-HBs positive rate of children who were immunized by the gene recombining vaccine might be descending following the age's dropping greatly, we should strengthen the serological surveillance of hepatitis B. The main cause that the children became the HBsAg carrier should be a vertical transmission.
Child ; Child, Preschool ; China ; epidemiology ; Follow-Up Studies ; Hepatitis B ; epidemiology ; immunology ; prevention & control ; Hepatitis B Antibodies ; blood ; Hepatitis B Surface Antigens ; blood ; Hepatitis B Vaccines ; immunology ; therapeutic use ; Hepatitis B virus ; immunology ; Humans ; Immunity, Active
8.Epidemiological effect of hepatitis B immunization among newborn babies in Beijing.
Xiao-hong GONG ; Li-rong LIU ; Lei JIA ; Yang-hua LI ; Yu-lan XING ; Quan-yi WANG
Chinese Journal of Hepatology 2003;11(4):201-202
OBJECTIVETo evaluate the epidemiological effect of hepatitis B immunization among newborn babies in Beijing.
METHODSA multistage sampling method was used for the collection of immunization cards, field epidemiological survey on hepatitis B virus (HBV) immunization of children, analysis of infectious disease reports. HBsAg, anti-HBs and anti-HBc levels were detected by solid phase radioimmunoassays (SPRIA).
RESULTSThe incidence of hepatitis B in children of 0 to 14 years at the beginning of HBV immunization was 18.59 to 20.52/100,000, and declined to 0.39 to 2.38/100,000 in 2000 (chi2 = 58.26, P < 0.01). The HBsAg carrying rate of the children decreased from 2.82% to 0.60%, about 80.00% after vaccination (chi2 = 10.75, P < 0.01).
CONCLUSIONHepatitis B vaccination of newborn babies is an effective measure for prevention and control of hepatitis B virus infection.
China ; epidemiology ; Female ; Hepatitis B ; epidemiology ; prevention & control ; Hepatitis B Surface Antigens ; blood ; immunology ; Hepatitis B Vaccines ; immunology ; Humans ; Incidence ; Infant, Newborn ; Male ; Seroepidemiologic Studies ; Vaccination
9.Incidence and Seroprevalence of Hepatitis A Virus Infections among Young Korean Soldiers.
Cheol In KANG ; Chang Min CHOI ; Tae Sung PARK ; Dong Jun LEE ; Myoung Don OH ; Kang Won CHOE
Journal of Korean Medical Science 2007;22(3):546-548
This study was performed to determine the incidence and seroprevalence of hepatitis A virus (HAV) infections in young soldiers in the Republic of Korea Army. From January 2000 through December 2004, a total of 147 hepatitis A cases were reported to the Armed Forces Medical Command. The annual incidence rates were 7.4 per 100,000 persons in 2000, 1.6 in 2001, 4.4 in 2002, 9.8 in 2003, and 6.2 in 2004, based on the reported cases among approximately 500,000 soldiers. All patients were males with a median age of 21 yr (range, 19-27). The most common symptom was nausea (86.5%), and all patients had recovered without complications. In addition, in order to evaluate the seroprevalence of HAV infection in young adults, serum samples were obtained from randomly selected young subjects among those who had been admitted to the Armed Forces Capital Hospital from September 2005 to February 2006. A total of 200 subjects were enrolled in the study to analyze the anti-HAV immune status. The overall anti-HAV IgG seropositive rate was 2% (4/200, 95% CI, 0.60-5.21%). Given the changing epidemiology of the disease and the associated increase in morbidity, it was suggested that the routine HAV vaccination for Korean military personnel might be necessary.
Adult
;
Hepatitis A/*blood/*epidemiology/immunology
;
Hepatitis A Antibodies/immunology
;
Hepatitis A virus/*metabolism
;
Humans
;
Immunoglobulin G/blood
;
Incidence
;
Korea
;
Male
;
Military Personnel
;
Seroepidemiologic Studies
10.Study on the effects of controlling hepatitis A epidemics by building the colony immune defence.
Yin-zhong CHEN ; Ren-jie JIANG ; Wen-xiang YU ; Cheng-hui LI
Chinese Journal of Epidemiology 2003;24(5):366-369
OBJECTIVETo build the colony immune defence and to control the periodic epidemics of hepatitis A after a mass vaccination of live attenuated hepatitis A vaccine.
METHODSThrough yearly observing the correlation of the accumulative inoculation rates of live attenuated hepatitis A vaccine, the crowd immune standard and the morbidity of hepatitis A after administered live attenuated hepatitis A vaccine among susceptible population and surveilling anti-HAV IgG in the different epidemic areas.
RESULTS(1) The accumulative inoculation rates of live attenuated hepatitis A vaccine was 34.15% in 8 years from 1993 to 2000, among which they were 84.46%, 82.23% and 15.14% in the preschool children, primary and middle school student and 15 - 45 age groups respectively. The morbidity of hepatitis A decreased to 8.26/100,000 in 2000. (2) The crowd positive rates of anti-HAV IgG were 74.24% in 1998 and 83.68% by 2000. Among which they were 74.02%, 68.49%, 79.41%, 85.71% and 90.80% in 2 - 4, 6 - 8, 13 - 15, 20- and 30 - 39 age groups respectively. (3) The accumulative inoculation rates were 37.36%, 51.08% and 28.68% in the inspection areas of Tongtai, Binhai and Yandu respectively. The crowd positive rates of anti-HAV IgG in three inspect area were 85.71%, 85.94% and 78.63% respectively. It was noticed the correlation between the accumulative inoculation rates and the crowd positive rates of anti-HAV IgG was (r(city) = 0.91, F = 15.10, P < 0.03).
CONCLUSIONThe results showed that the crowd positive rates of anti-HAV IgG had increased to 85% while, the colony immune defence of hepatitis A was effectively built to break the periodic epidemics of hepatitis A. The morbidity of hepatitis A decreased to the lowest level in the history.
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; China ; epidemiology ; Female ; Hepatitis A ; epidemiology ; prevention & control ; Hepatitis A Vaccines ; immunology ; Hepatitis A Virus, Human ; immunology ; Hepatitis Antibodies ; blood ; Humans ; Immunoglobulin G ; blood ; Male ; Mass Vaccination ; statistics & numerical data ; Middle Aged ; Vaccines, Attenuated ; immunology